Literature DB >> 2764374

Alcohol consumption and chronic obstructive pulmonary disease.

E Garshick1, M R Segal, T G Worobec, C M Salekin, M J Miller.   

Abstract

This study examined the relationship between lifetime alcohol consumption and respiratory symptoms in 195 subjects (including 111 alcoholics) and FEV1 level in 165 subjects (including 91 alcoholics). After adjustment for age and cigarette smoking status, using multiple logistic regression, lifetime alcohol consumption was a significant predictor of chronic cough and chronic phlegm, but not of any wheeze or persistent wheeze. Multiple linear regression analysis indicated that lifetime alcohol consumption was also a predictor of lower levels of FEV1 in a model that included age, pack-years of cigarette smoking, and an interaction between alcohol consumption and pack-years. The interaction between smoking and alcohol consumption was in a direction opposite to the independent effects of alcohol and smoking, suggesting a protective effect of alcohol with heavier amounts of smoking. Additional study is needed to further assess the relationship between respiratory symptoms and alcohol consumption, and between pulmonary function and alcohol consumption.

Entities:  

Mesh:

Year:  1989        PMID: 2764374     DOI: 10.1164/ajrccm/140.2.373

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  19 in total

1.  Evidence for a positive association between pulmonary function and wine intake in a population-based study.

Authors:  Holger J Schünemann; Brydon J B Grant; Jo L Freudenheim; Paola Muti; Susan E McCann; Deepa Kudalkar; Malathi Ram; Tom Nochajski; Marcia Russell; Maurizio Trevisan
Journal:  Sleep Breath       Date:  2002-12       Impact factor: 2.816

2.  Which etiology causes the most severe acute pancreatitis?

Authors:  P G Lankisch; C Assmus; D Pflichthofer; K Struckmann; D Lehnick
Journal:  Int J Pancreatol       Date:  1999-10

3.  Recent alcohol use prolongs hospital length of stay following lung transplant.

Authors:  Erin M Lowery; Meagan Yong; Arala Cohen; Cara Joyce; Elizabeth J Kovacs
Journal:  Clin Transplant       Date:  2018-06-20       Impact factor: 2.863

4.  B Cell-Activating Factor Is Associated with Testosterone and Smoking Status in Non-Ambulatory Men with Chronic Spinal Cord Injury.

Authors:  Ricardo A Battaglino; Nguyen Nguyen; Megan Summers; Leslie R Morse
Journal:  J Neurotrauma       Date:  2019-06-17       Impact factor: 5.269

Review 5.  Alcohol and airways function in health and disease.

Authors:  Joseph H Sisson
Journal:  Alcohol       Date:  2007-08-30       Impact factor: 2.405

6.  Predictors of cardiopulmonary hospitalization in chronic spinal cord injury.

Authors:  Anthony C Waddimba; Nitin B Jain; Kelly Stolzmann; David R Gagnon; James F Burgess; Lewis E Kazis; Eric Garshick
Journal:  Arch Phys Med Rehabil       Date:  2009-02       Impact factor: 3.966

7.  Persistent light to moderate alcohol intake and lung function: A longitudinal study.

Authors:  Monica M Vasquez; Duane L Sherrill; Tricia D LeVan; Wayne J Morgan; Joseph H Sisson; Stefano Guerra
Journal:  Alcohol       Date:  2017-09-01       Impact factor: 2.405

8.  Osteoporotic fractures and hospitalization risk in chronic spinal cord injury.

Authors:  L R Morse; R A Battaglino; K L Stolzmann; L D Hallett; A Waddimba; D Gagnon; A A Lazzari; E Garshick
Journal:  Osteoporos Int       Date:  2008-06-26       Impact factor: 4.507

9.  Increased mortality of acute upper gastrointestinal bleeding in patients with chronic obstructive pulmonary disease. A case controlled, multiyear study of 53 consecutive patients.

Authors:  M S Cappell; S C Nadler
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

10.  Relation of serum elastin peptide concentration to age, FEV1, smoking habits, alcohol consumption, and protease inhibitor phenotype: an epidemiological study in working men.

Authors:  C Frette; S M Wei; F Neukirch; R Sesboüé; J P Martin; M P Jacob; F Kauffmann
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.